COOPER COMPANIES, INC. COO

Latest FY: 2025 Healthcare Medical Instruments & Supplies
Market Price $76.13
Market Cap $14.93B
P/E Ratio 40.71
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑5.1% YoY
$4.09B
3-Yr CAGR: 7.3%
Net Income ↓-4.4% YoY
$374.90M
Net Margin: 9.2%
Free Cash Flow ↑50.5% YoY
$433.70M
FCF Yield: 2.91%
EPS (Diluted) ↓-4.6% YoY
$1.87
Basic: $1.88
Return on Equity Efficiency
4.6%
ROA: 116.9%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (COO)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $1,966.8M $1,173.1M $273.9M $1.40 $509.6M $357.0M
FY 2017 $2,139.0M +8.8% $1,365.8M $372.9M +36.1% $1.88 +34.5% $593.6M $466.4M +30.6%
FY 2018 $2,532.8M +18.4% $1,632.3M $139.9M -62.5% $0.70 -62.6% $668.9M $475.3M +1.9%
FY 2019 $2,653.4M +4.8% $1,756.8M $466.7M +233.6% $2.33 +232.0% $713.2M $421.1M -11.4%
FY 2020 $2,430.9M -8.4% $1,534.8M $238.4M -48.9% $1.20 -48.4% $486.6M $176.2M -58.2%
FY 2021 $2,922.5M +20.2% $1,955.8M $2,944.7M +1,135.2% $14.79 +1,129.9% $738.6M $524.2M +197.5%
FY 2022 $3,308.4M +13.2% $2,139.6M $385.8M -86.9% $1.94 -86.9% $692.4M $450.4M -14.1%
FY 2023 $3,593.2M +8.6% $2,357.9M $294.2M -23.7% $1.48 -23.8% $607.5M $215.0M -52.3%
FY 2024 $3,895.4M +8.4% $2,595.7M $392.3M +33.3% $1.96 +32.7% $709.3M $288.1M +34.0%
FY 2025 $4,092.4M +5.1% $2,682.1M $374.9M -4.4% $1.87 -4.6% $796.1M $433.7M +50.5%
$

Valuation

Market Price $76.13
Market Cap $14.93B
Enterprise Value $17.27B
P/E Ratio 40.71
P/B Ratio 1.80
FCF Yield 2.91%
Dividend Yield 2.47%
Shares Outstanding 194,900,000
%

Profitability & Margins

Gross Margin 65.54%
Operating Margin 16.69%
Net Margin 9.16%
Return on Equity (ROE) 4.55%
Return on Assets (ROA) 116.86%
Asset Turnover 12.76x
Revenue 3-Yr CAGR 7.35%
🛡️

Financial Health & Liquidity

Current Ratio 0.29
Cash Ratio 0.10
Debt / Equity 0.298
Debt / Assets 7.655
Cash & Equivalents $110.60M
Total Debt $2.46B
Book Value / Share $42.27
💧

Cash Flow Efficiency

Operating Cash Flow $796.10M
Capital Expenditures (CapEx) $362.40M
Free Cash Flow $433.70M
OCF / Revenue 19.45%
FCF / Revenue 10.60%
FCF 3-Yr CAGR -1.25%
🏷️

Per Share Metrics

EPS (Diluted) $1.87
EPS (Basic) $1.88
Dividends / Share $1.88
Book Value / Share $42.27
EPS YoY Growth -4.59%
🏛️

Balance Sheet (FY 2025)

Total Assets $320.80M
Total Liabilities $1.11B
Stockholders' Equity $8.24B
Current Assets $320.80M
Current Liabilities $1.11B